Skip to main content
OpenTrials

Clinical trial condition

Pruritus

Explore clinical trials studying Pruritus. Study availability and eligibility vary by location and protocol.

331 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Pruritus trial results

Completed

Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus

NCT02143973

Conditions
Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, +4 more
Locations
  • Nephrology Associates PC Birmingham, Alabama, United States
  • University South Alabama Medical Center Mobile, Alabama, United States
  • Arizona Kidney Disease and Hypertension Center Phoenix, Arizona, United States
  • U.S. Renal Care Inc. Pine Bluff, Arkansas, United States
View all 35 locations
View Trial Details
Completed

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

NCT02143648

Conditions
Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, +4 more
Locations
  • Nephrology Associates PC Birmingham, Alabama, United States
  • University South Alabama Medical Center Mobile, Alabama, United States
  • Arizona Kidney Disease and Hypertension Center Phoenix, Arizona, United States
  • U.S. Renal Care Inc Pine Bluff, Arkansas, United States
View all 47 locations
View Trial Details
Completed

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

NCT02174419

Conditions
Nodularis Prurigo, Pathological Conditions, Signs and Symptoms, Prurigo, +6 more
Locations
  • Case Western Reserve University Cleveland, Ohio, United States
  • Temple University Hospital Philadelphia, Pennsylvania, United States
  • University of Münster Münster, Germany
  • Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wroclawiu Wroclaw, Lower Silesian Voivodeship, Poland
View Trial Details
Completed

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

NCT03668613

Conditions
Disease Attributes, Moderate to Severe Chronic Plaque-Type Psoriasis, Pathologic Processes, +9 more
Locations
  • First OC Dermatology Fountain Valley, California, United States
  • Private Practice Jacksonville, Florida, United States
  • Novartis Investigative Site Lebanon, New Hampshire, United States
  • Texas Derm and Laser Specialists . San Antonio, Texas, United States
View all 23 locations
View Trial Details
Completed

A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis

NCT05870865

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
Locations
  • TrialSpark Investigative Site 0106 Scottsdale, Arizona, United States
  • TrialSpark Investigative Site 0118 Hot Springs, Arkansas, United States
  • TrialSpark Investigative Site 0123 Beverly Hills, California, United States
  • TrialSpark Investigative Site 0113 Fremont, California, United States
View all 27 locations
View Trial Details
Completed

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

NCT03858634

Conditions
Chronic Disease, Chronic Idiopathic Pruritus, Chronic Idiopathic Urticaria, +22 more
Locations
  • Site 106 Anniston, Alabama, United States
  • Site 110 Phoenix, Arizona, United States
  • Site 114 Hot Springs, Arkansas, United States
  • Site 103 Los Angeles, California, United States
View all 14 locations
View Trial Details

Related conditions